EXLS:NASDAQExlService Holdings, Inc. Analysis
Data as of 2026-04-01 - not real-time
$30.46
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
EXLS is trading at $30.46, about 5% below its 20‑day SMA of $30.70 and 9% under the 200‑day SMA of $39.85, indicating short‑term bearish pressure. Yet the stock sits above the identified support of $29.29 and below a clear resistance near $33.0, offering a modest upside cushion. Technical signals are mixed: RSI at 44 suggests neutral momentum, while the MACD histogram is positive, hinting at a potential near‑term bounce.
Fundamentally, the company posted a 12.7% YoY revenue increase to $542.6 M in Q4, beating earnings expectations with non‑GAAP EPS of $0.50. Its forward PE of 12.4 is well below the industry average of 33.2, and the DCF‑derived fair value of $36.9 implies roughly 37% upside. Strong ROE (27%) and free cash flow generation support the valuation, though a 37% 30‑day volatility and a beta of 0.74 introduce moderate risk. The market’s “Extreme Greed” sentiment (77.6 on the Fear & Greed Index) further underscores the potential for price appreciation if the bullish fundamentals hold.
Fundamentally, the company posted a 12.7% YoY revenue increase to $542.6 M in Q4, beating earnings expectations with non‑GAAP EPS of $0.50. Its forward PE of 12.4 is well below the industry average of 33.2, and the DCF‑derived fair value of $36.9 implies roughly 37% upside. Strong ROE (27%) and free cash flow generation support the valuation, though a 37% 30‑day volatility and a beta of 0.74 introduce moderate risk. The market’s “Extreme Greed” sentiment (77.6 on the Fear & Greed Index) further underscores the potential for price appreciation if the bullish fundamentals hold.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Price near technical support
- Mixed MACD/RSI signals
- Recent earnings beat
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- 12.7% revenue growth YoY
- Forward PE well below industry average
- DCF upside of ~37%
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Strong ROE and free cash flow generation
- Strategic positioning in AI‑driven data services
- Attractive valuation relative to peers
Key Metrics & Analysis
Financial Health
Revenue Growth12.70%
Profit Margin12.02%
P/E Ratio19.8
ROE27.25%
ROA11.80%
Debt/Equity44.46
P/B Ratio5.2
Op. Cash Flow$350.7M
Free Cash Flow$257.5M
Industry P/E33.2
Technical Analysis
TrendBearish
RSI44.0
Support$29.29
Resistance$32.98
MA 20$30.70
MA 50$32.55
MA 200$39.85
MACDBullish
VolumeStable
Fear & Greed Index77.61
Valuation
Fair Value$36.92
Target Price$41.71
Upside/Downside36.95%
GradeUndervalued
TypeBlend
Risk Assessment
Beta0.74
Volatility36.97%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.